Condition: Colo-rectal Cancer · Sponsor: Niguarda Hospital
Observational, retrospective and prospective multicentric Italian study of patients diagnosed with colorectal cancer between age 18-40, aiming at underpinning the biology of vEO-CRC, including colibactin as well as a broader proteo-genomic characterization, to identify potential new therapeutic targets specifically directed to this peculiar subset of patients.
This description comes directly from the study's public registry record.
Salvatore Siena, MD · +39 02 6444 · salvatore.siena@ospedaleniguarda.it
Andrea Sartore Bianchi, MD · +39 02 6444 · andrea.sartorebianchi@ospedaleniguarda.it
Always discuss trial participation with your own doctor first.
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Milano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06965335